Spatial transcriptomics reveals IFN-γ–driven HLA-II up-regulation co-localises with LAG - 3+ CD4 T cells in 70% of GBM biopsies, rationalising dual PD - 1/LAG-3 blockade under investigation. The gene discussed is RPL17; the disease is glioblastoma.